Accelerating precision exercise medicine in cancer patients using pooled individual patient data: POLARIS experience
JNCI Cancer Spectrum · 2025
DOI: 10.1093/jncics/pkaf078 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Laurien M Buffart und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Precision Medicine, Exercise Therapy. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Numerous exercise oncology trials have been completed, greatly informing exercise recommendations for patients with cancer. Exercise medicine can be administered in various types, doses, and schedules at various time points. Advancing precision exercise medicine requires understanding of how the effects of different exercise interventions vary by characteristics of individual patients. The Predicting OptimaL cAncer RehabIlitation and Supportive care (POLARIS) study provides an international infrastructure and shared database to perform pooled analyses of individual patient data (IPD) from multiple randomized controlled trials. This commentary aims to highlight the value of pooled IPD analyses, summarize key findings from published pooled IPD analyses on the effects of physical exercise on various outcomes, and provide guidance to advance precision exercise medicine for patients with cancer. POLARIS currently includes IPD from 52 exercise trials. Findings to date indicate that exercise interventions in patients with cancer have beneficial effects on physical fitness, fatigue, health-related quality of life, self-reported cognition (posttreatment), sleep disturbances, and symptoms of anxiety and depression. Additionally, it was determined that the exercise effects varied by characteristics of the patients, including the initial value of the outcome, age, marital status, and education level, and by characteristics of the intervention, including exercise supervision and specificity. Future research opportunities to advance precision exercise medicine for patients with cancer include pooling of trial data from understudied populations, data on clinical outcomes, and biomarkers, as well as applying machine learning models for identifying combinations of covariables that modify intervention effects and predictions of individual treatment effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
- Exercise Medicine Research Institute, Edith Cowan University, Joondalup, WA, Australia.
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
- Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, Canada.
ORCID-Profile: Laurien M Buffart, Marlou-Floor Kenkhuis, Robert U Newton, Anne M May, Daniel A Galvão, Kerry S Courneya
Zitieren
APA
Buffart, L. M., Kenkhuis, M. F., Newton, R. U., May, A. M., Galvão, D. A., & Courneya, K. S. (2025). Accelerating precision exercise medicine in cancer patients using pooled individual patient data: POLARIS experience. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf078
Vancouver
Buffart LM, Kenkhuis MF, Newton RU, May AM, Galvão DA, Courneya KS. Accelerating precision exercise medicine in cancer patients using pooled individual patient data: POLARIS experience. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf078
BibTeX
@article{Buffart2025,
author = {Buffart, Laurien M and Kenkhuis, Marlou-Floor and Newton, Robert U and May, Anne M and Galvão, Daniel A and Courneya, Kerry S},
title = {Accelerating precision exercise medicine in cancer patients using pooled individual patient data: POLARIS experience},
journal = {JNCI Cancer Spectrum},
year = {2025},
doi = {10.1093/jncics/pkaf078}
}
EUVIMED